Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Paracrine signaling is a form of cell-to-cell communication in which cells produce signals—such as cytokines—that affect nearby target cells within the same tissue or microenvironment. In the context of regeneration, paracrine signaling refers to the release of biologically active molecules (notably cytokines and growth factors) by one cell type, such as stem or immune cells, to influence neighboring cells and orchestrate tissue repair and regeneration. Key cytokines involved include interleukins (e.g., IL-6), chemokines, VEGF, and FGF. Paracrine cytokine signaling is critical for promoting proliferation and differentiation of resident progenitor/stem cells, enhancing cytoprotection/survival after injury, stimulating neovascularization/angiogenesis, modulating inflammatory responses, and limiting fibrosis/scarring by influencing fibroblast activity. The composition of the paracrine secretome adapts over time following injury. Early phases are dominated by pro-inflammatory signals; later phases shift toward anti-inflammatory/regenerative cues.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Paracrine Signaling (Cytokine-Mediated Regenerative Response) (None).